Onderzoeker
Guido Vanham
Affiliaties
- Virologie (Onderzoekseenheid)
Lid
Vanaf1 jan 1989 → 30 jul 2019
Projecten
1 - 10 of 19
- Machine learning framework voor T-cell receptor repertoiregebaseerde virale diagnostiekVanaf3 nov 2020 → Heden
- Evaluation of the role of immune checkpoint molecules in the natural killer cell-mediated anti-HIV responseVanaf11 apr 2019 → Heden
- Ontwikkeling van een nieuwe nanopartikel-formulatie voor een therapeutisch vaccin gebasseerd op mRNA tegen HIVVanaf11 apr 2019 → Heden
- Immuno Cytometry : Phenotyping immune cellular components, in the context of HBV, HIV and AD, by new, advanced technologiesVanaf18 jan 2018 → 17 aug 2020
- Interventions towards a functional cure: detailed phenotyping of the HIV-specific polyfunctional CD8+ T cell responses of controllersVanaf24 jun 2016 → 12 feb 2020
- Search for host genetic factors associated with neurological complications (HAM/TSP) in Peruvian HTLV-1 infected individualsVanaf18 mei 2016 → 27 sep 2016
- Rationeel ontwerp van een therapeutisch vaccin tegen HIV-1 gebaseerd op een nieuwe formulering van nanopartikelVanaf1 jan 2016 → 31 dec 2020
- Cell-associated HIV-RNA as a superior marker of treatment success or failureVanaf29 apr 2015 → 19 sep 2019
- Therapeutic TriMix/Mrna BASED Vaccine in Chronic HIV-1 Infected Patients Receiving Antiretroviral TherapyVanaf1 dec 2013 → 31 dec 2017
- Inductie van breed-potente Hiv-1 suppressieve immuun responsen door dendritische cellen opgeladen met gag mRNA.Vanaf1 jan 2011 → 21 mrt 2019
Publicaties
41 - 50 van 206
- Characterization of humoral responses to soluble trimeric HIV gp140 from a clade A Ugandan field isolate(2013)
Auteurs: M.L. Visciano, M. Tagliamonte, G. Stewart-Jones, L Heyndrickx, G Vanham, M. Jansson, A. Fomsgaard, B. Grevstad, M. Ramaswamy, F.M. Buonaguro, et al.
Pagina's: 1-11 - Type I IFN counteracts the induction of antigen-specific immune responses by lipid-based delivery of mRNA vaccines(2013)
Auteurs: C Pollard, J Rejman, W De Haes, B. Verrier, E. Van Gulck, T. Naessens, S. De Smedt, P. Bogaert, J. Grooten, G Vanham, et al.
Pagina's: 251-259 - The N276 glycosylation site is required for HIV-1 neutralization by the CD4 binding site specific HJ16 monoclonal antibody(2013)
Auteurs: SS Balla-Jhagjhoorsingh, D. Corti, L Heyndrickx, B Willems, K Vereecken, D. Davis, G Vanham
Pagina's: e68863 - In vitro and ex vivo evaluation of polymeric nanoparticles for vaginal and rectal delivery of the anti-HIV drug dapivirine(2013)
Auteurs: J. das Neves, F. Araujo, F. Andrade, J Michiels, Kevin Ariën, G Vanham, M. Amiji, M.F. Bahia, B. Sarmento
Pagina's: 2793-2807 - Interfacial cavity filling to optimize CD4-mimetic miniprotein interactions with the HIV-1 surface protein(2013)
Auteurs: L. Morellato-Castillo, P. Acharya, O. Combes, J Michiels, A Descours, O.H. Ramos, Y. Yang, G Vanham, Kevin Ariën, P.D. Kwong, et al.
Pagina's: 5033-5047 - Targeting of human antigen-presenting cell subsets(2013)
Auteurs: C. Goyvaerts, J. Dingemans, K. De Groeve, C. Heirman, E. Van Gulck, G Vanham, P. De Baetselier, K. Thielemans, G. Raes, K. Breckpot
Pagina's: 11304-11308 - Selected HIV-1 env trimeric formulations act as potent immunogens in a rabbit vaccination model(2013)
Auteurs: L Heyndrickx, G. Stewart-Jones, M. Jansson, H. Schuitemaker, E. Bowles, L. Buonaguro, B. Grevstad, L. Vinner, K Vereecken, J. Parker, et al.
Pagina's: e74552 - Diaryltriazine non-nucleoside reverse transcriptase inhibitors are potent candidates for pre-exposure prophylaxis in the prevention of sexual HIV transmission(2013)
Auteurs: Kevin Ariën, M. Venkatraj, J Michiels, J. Joossens, K Vereecken, P. Van der Veken, Said Abdellati, Vicky Cuylaerts, Tania Crucitti, L Heyndrickx, et al.
Pagina's: 2038-2047 - M48U1 CD4 mimetic has a sustained inhibitory effect on cell-associated HIV-1 by attenuating virion infectivity through gp120 shedding(2013)
Auteurs: P Selhorst, K. Grupping, T. Tong, E.T. Crooks, L. Martin, Guido Vanham, J.M. Binley, Kevin Ariën
Pagina's: 1-9 - Possible implication of NFKB1A and NKG2D genes in susceptibility to HTLV-1-associated myelopathy/tropical spastic paraparesis in Peruvian patients infected with HTLV-1(2012)
Auteurs: M Talledo, G Lopez, JR Huyghe, K Verdonck, E González, D. Clark, G Vanham, E. Gotuzzo, G Van Camp, L Van Laer
Pagina's: 319-326